Kolon TissueGene recorded a decline of more than 10% during trading on the 30th, falling to the 11,000-won range. As a sharp correction continues from its peak in May, market attention is focused on whether the stock can defend the 10,000-won level, a key psychological support line.

As of 12:43 p.m. on the 30th, Kolon TissueGene is trading at 11,840 won, down 1,360 won (10.30%) from the previous trading day. During the session, the decline widened further, with the stock dropping to the 11,000-won range. Stock price volatility has recently expanded amid ongoing uncertainty surrounding clinical trial results and regulatory disclosures.

At the same time, the domestic stock market is showing mixed performance. The KOSPI is fluctuating around the unchanged mark, down 1.85 points (0.03%) from the previous trading day at 5,661.39, while the KOSDAQ fell 10.98 points (1.65%) to 651.70, showing a relatively larger decline. With differentiated trends across indices, stock-level volatility is also expanding. Market participants note that price movements driven by individual company issues should be closely monitored.

[Investment decisions are the sole responsibility of the individual investor, and given the expanded short-term volatility, a cautious approach is advised.]